Yanyu Wu, PhD

home / authors / yanyu-wu-phd

Articles

October 25th 2017

The Option Value of Innovative Treatments for Non–Small Cell Lung Cancer and Renal Cell Carcinoma

Julia Thornton Snider, PhD Katharine Batt, MD, MSc Yanyu Wu, PhD Mahlet Gizaw Tebeka, MS Seth Seabury, PhD

Option value is the benefit a therapy provides patients by enabling them to survive to the next innovation.

December 5th 2016

The Social Value of Childhood Vaccination in the United States

Tomas J. Philipson, PhD Julia Thornton Snider, PhD Ayman Chit, PhD Sarah Green, BA Philip Hosbach, BA Taylor Tinkham Schwartz, MPH Yanyu Wu, PhD Wade M. Aubry, MD

Vaccination of children born in the United States in 2009 will save 1.2 million quality-adjusted life-years, generating $184 billion in social value net of vaccination costs.

June 17th 2016

Impact of Type 2 Diabetes Medication Cost Sharing on Patient Outcomes and Health Plan Costs

Julia Thornton Snider, PhD Seth Seabury, PhD Janice Lopez, PharmD, MPH Scott McKenzie, MD Yanyu Wu, PhD Dana P. Goldman, PhD

An analysis of claims from over 90,000 patients with type 2 diabetes (T2D) demonstrates that increased medication cost sharing is associated with higher rates of hospitalization and increased plan costs.